A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial

Post time 5 day(s) ago

journal：European Heart Journal

Authors：Alexandra J Lansky; Rajendra Makkar; Tamim Nazif; Steven Messé; John Forrest; Rahul Sharma; Joachim Schofer; Axel Linke; David Brown; Abhijeet Dhoble; Phillip Horwitz; Ming Zang; Frederico DeMarco; Vivek Rajagopal; Michael G Dwyer; Robert Zivadinov; Pieter Stella; Joshua Rovin; Helen Parise; Susheel Kodali; Andreas Baumbach; Jeffrey Moses

Published date：2021-7-15

DOI：10.1093/eurheartj/ehab213

PDF link：https://academic.oup.com/eurhear ... 6623108/ehab213.pdf

Article link：https://doi.org/10.1093/eurheartj/ehab213

Article Source：Oxford University Press (OUP)。

Remark：

Post time 5 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 4 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Oxford] A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial Copy